Evaluation of the Effect of Serratus Anterior Plane Block for Pain Treatment After Video-Assisted Thoracoscopic Surgery
Overview
- Phase
- Not Applicable
- Intervention
- Serratus Anterior Plane Block
- Conditions
- Nerve Block
- Sponsor
- Bursa Yüksek İhtisas Education and Research Hospital
- Enrollment
- 40
- Primary Endpoint
- Visual Analogue Scale
- Status
- Completed
- Last Updated
- 8 years ago
Overview
Brief Summary
Analgesia following video-assisted thoracoscopic surgery (VATS) is important for the prevention of postoperative pulmonary complications.Various regional methods of anesthesia are currently being used to achieve this goal. The aim of the study was to assess the effectiveness of SAPB on postoperative VATS analgesia.
Investigators
Korgün Ökmen
Principal Investigator
Bursa Yüksek İhtisas Education and Research Hospital
Eligibility Criteria
Inclusion Criteria
- •Patients who were in the American Society of Anesthesiologists (ASA) I-III class and underwent video-assisted thoracoscopic surgery (VATS).
Exclusion Criteria
- •Previous history of opioid use preoperatively,
- •Allergy to local anesthetics,
- •The presence of any systemic infection,
- •Uncontrolled arterial hypertension,
- •Uncontrolled diabetes mellitus.
Arms & Interventions
Group S
IV patient-controlled analgesia (PCA) tramadol+Serratus Anterior Plane Block(SAPB) Tramadol infusion (PCA): 400 mg tramadol, IV 4 mg/mL tramadol solution into 100 mL normal saline; PCA settings: 0.3 mg/kg bolus, 10 mg Demand dose and 20 min lock out interval, six-hour limit infusion to attain 100 mg. Maximum daily dose was set at 400 mg. 20 mL of bupivacaine at a concentration of 0.25% to between serratus anterior and intercostal muscle using the in-line technique for SAPB.
Intervention: Serratus Anterior Plane Block
Group S
IV patient-controlled analgesia (PCA) tramadol+Serratus Anterior Plane Block(SAPB) Tramadol infusion (PCA): 400 mg tramadol, IV 4 mg/mL tramadol solution into 100 mL normal saline; PCA settings: 0.3 mg/kg bolus, 10 mg Demand dose and 20 min lock out interval, six-hour limit infusion to attain 100 mg. Maximum daily dose was set at 400 mg. 20 mL of bupivacaine at a concentration of 0.25% to between serratus anterior and intercostal muscle using the in-line technique for SAPB.
Intervention: IV patient-controlled analgesia (PCA) tramadol
Group T
IV patient-controlled analgesia (PCA) tramadol Tramadol infusion (PCA): 400 mg tramadol, IV 4 mg/mL tramadol solution into 100 mL normal saline; PCA settings: 0.3 mg/kg bolus, 10 mg Demand dose and 20 min lock out interval, six-hour limit infusion to attain 100 mg. Maximum daily dose was set at 400 mg.
Intervention: IV patient-controlled analgesia (PCA) tramadol
Outcomes
Primary Outcomes
Visual Analogue Scale
Time Frame: Postoperative 24 hours
Visual Analogue Scale was used for pain
Secondary Outcomes
- tramadol consumption(Postoperative 24 hour)
- Ramsay sedation scale (RSS)(24 hours)